Literature DB >> 27325876

Safety of chronic transdermal fentanyl use in patients receiving hemodialysis.

Jin Han1, Santosh L Saraf2, Victor R Gordeuk2, Michel Gowhari3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27325876      PMCID: PMC5378007          DOI: 10.2146/ajhp150748

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  8 in total

1.  Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure.

Authors:  S Mercadante; M Caligara; M Sapio; R Serretta; F Lodi
Journal:  J Pain Symptom Manage       Date:  1997-04       Impact factor: 3.612

2.  Fentanyl pharmacokinetics in patients undergoing renal transplantation.

Authors:  D E Koehntop; J H Rodman
Journal:  Pharmacotherapy       Date:  1997 Jul-Aug       Impact factor: 4.705

3.  Nondialyzability of fentanyl with high-efficiency and high-flux membranes.

Authors:  J Joh; M K Sila; B Bastani
Journal:  Anesth Analg       Date:  1998-02       Impact factor: 5.108

4.  Morphine intoxication in renal failure: the role of morphine-6-glucuronide.

Authors:  R J Osborne; S P Joel; M L Slevin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-14

Review 5.  A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.

Authors:  S King; K Forbes; G W Hanks; C J Ferro; E J Chambers
Journal:  Palliat Med       Date:  2011-07       Impact factor: 4.762

6.  Case report. Intravenous fentanyl patient-controlled analgesia for perioperative treatment of neuropathic/ischaemic pain in haemodialysis patients: a case series.

Authors:  M Karanikolas; D Aretha; P Kiekkas; G Monantera; I Tsolakis; K S Filos
Journal:  J Clin Pharm Ther       Date:  2010-10       Impact factor: 2.512

Review 7.  Upper extremity diabetic muscle infarction in three patients with end-stage renal disease: a case series and review.

Authors:  Raman Joshi; Bajinder Reen; Hilarie Sheehan
Journal:  J Clin Rheumatol       Date:  2009-03       Impact factor: 3.517

8.  Intravenous fentanyl kinetics.

Authors:  D A McClain; C C Hug
Journal:  Clin Pharmacol Ther       Date:  1980-07       Impact factor: 6.875

  8 in total
  4 in total

Review 1.  Assessing and Treating Chronic Pain in Patients with End-Stage Renal Disease.

Authors:  Flaminia Coluzzi
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

Review 2.  Opioids Preconditioning Upon Renal Function and Ischemia-Reperfusion Injury: A Narrative Review.

Authors:  Julio Palomino; Raquel Echavarria; Adriana Franco-Acevedo; Bibiana Moreno-Carranza; Zesergio Melo
Journal:  Medicina (Kaunas)       Date:  2019-08-23       Impact factor: 2.430

3.  Opioid Safety and Concomitant Benzodiazepine Use in End-Stage Renal Disease Patients.

Authors:  Rupam Ruchi; Shahab Bozorgmehri; Tezcan Ozrazgat-Baslanti; Mark S Segal; Ashutosh M Shukla; Rajesh Mohandas; Sanjeev Kumar
Journal:  Pain Res Manag       Date:  2019-10-20       Impact factor: 3.037

Review 4.  The Role of Opioids in Pain Management in Elderly Patients with Chronic Kidney Disease: A Review Article.

Authors:  Sanam Dolati; Faezeh Tarighat; Fariba Pashazadeh; Kavous Shahsavarinia; Saina Gholipouri; Hassan Soleimanpour
Journal:  Anesth Pain Med       Date:  2020-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.